help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 5, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1874
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/4/1418    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welzel, M.
Right arrow Articles by Riepe, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welzel, M.
Right arrow Articles by Riepe, F. G.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology

Submitted on August 21, 2007
Accepted on January 29, 2008

Carboxyterminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia

Maik Welzel, Nele Wüstemann, Gunter Simic-Schleicher, Helmuth G. Dörr, Egbert Schulze, Guftar Shaikh, Peter Clayton, Joachim Grötzinger, Paul-Martin Holterhus, and Felix G. Riepe*

Division of Pediatric Endocrinology (M.W., N.W., P.M.H., F.G.R.), Department of Pediatrics, Christian-Albrechts Universität zu Kiel, 24105 Kiel, Germany; Children's Hospital of Bremen-Nord (G.S.S.), 28755 Bremen, Germany; Division of Pediatric Endocrinology (H.G.D.), Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany; Laboratory of Molecular Genetics (E.S.), 69121 Heidelberg, Germany; University of Manchester (G.S., P.C.), Manchester M13 9PL, United Kingdom; Institute of Biochemistry (J.G.), Christian-Albrechts-Universität zu Kiel, 24098 Kiel, Germany

* To whom correspondence should be addressed. E-mail: friepe{at}pediatrics.uni-kiel.de.

Introduction: 3-{beta}-hydroxysteroid dehydrogenase (3{beta}-HSD) deficiency is a rare cause of congenital adrenal hyperplasia caused by inactivating mutations in the HSD3B2 gene. Most mutations are located within domains regarded crucial for enzyme function. The function of the c-terminus of the 3{beta}-HSD protein is not known.

Objective: We studied the functional consequences of three novel c-terminal mutations in the 3{beta}-HSD protein (p.P341L, p.R335X and p.W355X), detected in unrelated 46,XY neonates with classical 3{beta}-HSD type II deficiency showing different degrees of under-virilization.

Methods and Results: In vitro expression of the two truncated mutant proteins yielded absent conversion of pregnenolone and dehydroepiandrosterone (DHEA), whereas the missense mutation p.P341L showed a residual DHEA conversion of 6% of wild-type activity. Additional analysis of p.P341L, including three dimensional protein modeling, revealed that the mutant's inactivity predominantly originates from a putative structural alteration of the 3{beta}-HSD protein and is further aggravated by increased protein degradation. The stop mutations cause truncated proteins missing the final G-helix what abolishes enzymatic activity irrespective of an augmented protein degradation. Genital appearance did not correlate with the mutants' residual in vitro activity.

Conclusions: Three novel c-terminal mutants of the HSD3B2 gene are responsible for classical 3{beta}-HSD deficiency. The c-terminus is essential for the enzymatic activity. However, further studies are needed to clarify the exact function of this part of the protein. Our results indicate that the genital phenotype in 3{beta}-HSD deficiency cannot be predicted from in vitro 3{beta}-HSD function alone.


Key words: congenital adrenal hyperplasia • HSD3B2 • carboxyterminal • point mutation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society